CN102631478A - Chinese medicament for treating cirrhosis - Google Patents

Chinese medicament for treating cirrhosis Download PDF

Info

Publication number
CN102631478A
CN102631478A CN2012100957748A CN201210095774A CN102631478A CN 102631478 A CN102631478 A CN 102631478A CN 2012100957748 A CN2012100957748 A CN 2012100957748A CN 201210095774 A CN201210095774 A CN 201210095774A CN 102631478 A CN102631478 A CN 102631478A
Authority
CN
China
Prior art keywords
chinese medicine
parts
chinese
fine powder
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012100957748A
Other languages
Chinese (zh)
Inventor
刘新壮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lvyuan Qiuzheng Technology Development Co Ltd
Original Assignee
Lvyuan Qiuzheng Technology Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lvyuan Qiuzheng Technology Development Co Ltd filed Critical Lvyuan Qiuzheng Technology Development Co Ltd
Priority to CN2012100957748A priority Critical patent/CN102631478A/en
Publication of CN102631478A publication Critical patent/CN102631478A/en
Pending legal-status Critical Current

Links

Abstract

The invention provides a Chinese medicament for treating cirrhosis, which belongs to the field of Chinese medicaments for treating digestive system diseases, and has good effect and quick response. The Chinese medicament is prepared from Chinese violet, ganoderma lucidum, Chinese angelica, pseudo-ginseng, mulberry, turtle shell and other raw materials, has the effects of reinforcing vital energy and consolidating constitution, invigorating vital energy and nourishing blood, nourishing blood and liver, softening hardness to dissipate stagnation, activating blood circulation, removing stasis and relieving pains, and has the advantages of remarkable effect, definite drug effect and quick response.

Description

A kind of Chinese medicine of treating liver cirrhosis
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
Be used to treat the Chinese medicine of liver cirrhosis at present; The deficiency that has two aspects: the one, effect is obvious inadequately; The 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
To problem set forth above, the present invention provides a kind of Chinese medicine of treating liver cirrhosis, and it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect; The slower problem that takes effect, effective, instant effect, it is remarkable to have effect; Drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention realizes through following technical scheme:
1, a kind of Chinese medicine of treating liver cirrhosis adopts the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Violae 5---18 parts of 15 portions of Ganodermas 6---18 parts of Radix Angelicae Sinensis 6---
Radix Notoginseng 1---18 parts in 3 portions of Fructus Moris 4---12 parts of Carapax Trionycis 6---
The Chinese medicine of this treatment liver cirrhosis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Violae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.We think in research, hypoimmunity, and positive QI-insufficiency is hepatic fibrosis, liver cirrhosis incidence and development and the deciding factor that lapses to.So this disease " refractory " is referred to as " persistent ailment ", so effect " humble ", obstinate, the underlying cause just are the decisive role to immunity of organisms (setting upright), and not enough on the understanding, dynamics is also little.In view of the above, the present invention attaches most importance to set upright, and in conjunction with the pathological characters of liver cirrhosis behind the liver cirrhosis especially viral hepatitis, adopts the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, heat-clearing and toxic substances removing, hard masses softening and resolving is obtained remarkable result.The significance outstanding behaviours of this curative effect is aspect two: the one, and " dull pain in liver " that is difficult to overcome obviously alleviated, even complete obiteration; The 2nd, " the hepatic fibrosis reverse " that is difficult to realize realizes basically or fully.Ganoderma, Fructus Mori the body resistance strengthening and constitution consolidating among the we, benefiting QI and nourishing blood, tonification the five internal organs, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Notoginseng blood-nourishing blood-generating, promoting blood circulation, removing blood stasis and relieving pain, nourishing the liver easing the affected liver; Assistant is apt to control the pathopyretic ulcer red and swollen heat pain with the Herba Violae heat-clearing and toxic substances removing; Carapax Trionycis tonifying YIN and heat extraction, removing blood stasis and hard masses softening and resolving are to alleviate hepatic fibrosis.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, nourishing the liver easing the affected liver, and hard masses softening and resolving, the merit of promoting blood circulation, removing blood stasis and relieving pain, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
Through following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Herba Violae 500 kairine sesames 600 gram Radix Angelicae Sinensis 600 grams
Radix Notoginseng 100 gram Fructus Moris 400 gram Carapax Trionycis 600 grams
Press predetermined weight, Ganoderma is extracted with decoction and alcohol sedimentation technique; With conventional water extraction process Herba Violae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted, process extract fine powder 270 grams altogether, Radix Notoginseng is ground into fine powder; Mix with said extracted thing fine powder; Stir, process fine particle, the capsule of packing into No. 0; Process 1233 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
2, get following prescription (weight is unit by gram):
Herba Violae 1000 kairine sesames 1200 gram Radix Angelicae Sinensis 1200 grams
Radix Notoginseng 200 gram Fructus Moris 900 gram Carapax Trionycis 1200 grams
By above-mentioned same method, process 2500 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
3, get following prescription (weight is unit by gram):
Herba Violae 1500 kairine sesames 1800 gram Radix Angelicae Sinensis 1800 grams
Radix Notoginseng 300 gram Fructus Moris 1200 gram Carapax Trionycis 1800 grams
By above-mentioned same method, process 3700 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
4, get following prescription (by weight):
8 parts of 8 parts of Radix Angelicae Sinensis of 6 portions of Ganodermas of Herba Violae
8 parts of 5 parts of Carapax Trionycis of 1 portion of Fructus Mori of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
5, get following prescription (by weight):
15 parts of 15 parts of Radix Angelicae Sinensis of 12 portions of Ganodermas of Herba Violae
15 parts of 8 parts of Carapax Trionycis of 2 portions of Fructus Moris of Radix Notoginseng
By above-mentioned same method, process Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.3 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 21 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially, and remarkable fibrosis is arranged; Hepatic ascites appears in jaundice, anemia; Liver palm, spider angioma, cutaneous pigmentation and edema appear; CT examination is because the liver surface due to the regenerated nodule is not whole.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 9 examples, women's 12 examples do not have other serious disease, and the age is 47 years old-79 years old, 60.8 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears, the hepatic ascites complete obiteration; Hepatic fibrosis inspection index is obviously alleviated; CT examination, liver surface are not whole to be alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema, hepatic ascites etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking the Chinese medicinal capsule that the specific embodiment of the invention 2 is made, observed 6 months, is a course of treatment.Instructions of taking: every day 2 times, each 4 capsules, every capsules include Chinese medicine fine powder and extract 0.3 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 6 months after, symptom is obviously improved.21 philtrums of clinical experiment, produce effects 10 people, effective 9 people, invalid 2 people, total effective rate 90.4%.

Claims (1)

1. Chinese medicine of treating liver cirrhosis is characterized in that: said Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Herba Violae 5---18 parts of 15 portions of Ganodermas 6---18 parts of Radix Angelicae Sinensis 6---
Radix Notoginseng 1---18 parts in 3 portions of Fructus Moris 4---12 parts of Carapax Trionycis 6---
The Chinese medicine of this treatment liver cirrhosis is processed by following method:
(1) by above-mentioned weight ratio, Ganoderma is extracted ganoderan with decoction and alcohol sedimentation technique, technological process is following: Ganoderma is broken into graininess, crosses 40 mesh sieves Hot water (95 ℃) lixiviate with 1:20 Lixiviating solution decompression, concentrated 95% ethanol with 3 times of volumes mixes, left standstill 10-12 hours, centrifugal Add 75% ethanol, the deposition polysaccharide Dry the ganoderan extract fine powder;
(2) by above-mentioned weight ratio, Herba Violae, Radix Angelicae Sinensis, Fructus Mori, Carapax Trionycis are extracted through conventional water extraction process, process extractum, oven dry is pulverized, and gets the extract fine powder;
(3) by above-mentioned weight ratio, Radix Notoginseng is ground into fine powder, mixes, stir, process Chinese medicine granules, capsule, tablet with above-mentioned (1), (2) two kinds of extract fine powders.
CN2012100957748A 2012-04-04 2012-04-04 Chinese medicament for treating cirrhosis Pending CN102631478A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012100957748A CN102631478A (en) 2012-04-04 2012-04-04 Chinese medicament for treating cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012100957748A CN102631478A (en) 2012-04-04 2012-04-04 Chinese medicament for treating cirrhosis

Publications (1)

Publication Number Publication Date
CN102631478A true CN102631478A (en) 2012-08-15

Family

ID=46616158

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012100957748A Pending CN102631478A (en) 2012-04-04 2012-04-04 Chinese medicament for treating cirrhosis

Country Status (1)

Country Link
CN (1) CN102631478A (en)

Similar Documents

Publication Publication Date Title
CN102048831A (en) Traditional Chinese medicine for treating cirrhosis
CN102379924A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102091130A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102172369A (en) Chinese medicine for treating hepatocirrhosis
CN102302558A (en) Chinese medicament for treating hepatocirrhosis
CN102389482A (en) Traditional Chinese medicine for treating cirrhosis
CN102389498A (en) Traditional Chinese medicine for curing diabetic diarrhea
CN101953893A (en) Traditional Chinese medicine for treating cirrhosis
CN102068569A (en) Traditional Chinese medicine for treating cirrhosis
CN102114080A (en) Traditional Chinese medicine for treating cirrhosis
CN102389462A (en) Chinese medicine for treating cirrhosis
CN102670725A (en) Traditional Chinese medicine for curing cirrhosis
CN102379923A (en) Traditional Chinese medicine for treating cirrhosis
CN102389461A (en) Traditional Chinese medicine for treating cirrhosis
CN101966230A (en) Traditional Chinese medicine for treating cirrhosis
CN102380023A (en) Chinese medicament for treating benign prostatic hyperplasia
CN102389477A (en) Traditional Chinese medicine for treating benign prostatic hyperplasia
CN101991652A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102138983A (en) Traditional Chinese medicine for treating hepatocirrhosis
CN101953891A (en) Chinese medicament for treating hepatocirrhosis
CN102631478A (en) Chinese medicament for treating cirrhosis
CN102614257A (en) Traditional Chinese medicine for treatment of cirrhosis
CN102626445A (en) Traditional Chinese medicine for treating cirrhosis
CN102379929A (en) Traditional Chinese medicine for treating liver cirrhosis
CN102671062A (en) Chinese medicine for treating liver cirrhosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120815